Healthpeak Properties (DOC)

NYSE Real Estate Health Care REITs S&P 500
$20.26
+0.14 (+0.70%)
Close of Nov 06, 2026 · end-of-day data
Source: Healthpeak Properties's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$2.13B$524.27M$144.22M$144.33M$436.49M$471.32M$494.94M$527.42M$568.48M$603.99M
Cost of revenue$738.40M$666.25M$378.66M$405.24M$782.54M$773.28M$862.99M$902.06M$1.07B—
Gross profit$1.39B-$141.98M-$234.44M-$260.92M-$346.05M-$301.95M-$368.06M-$374.64M-$506.39M—
Interest expense$464.40M$307.72M$261.28M$217.61M$218.34M$157.98M$172.94M$200.33M$280.43M$305.18M
Pre-tax income$11.36M$10.90M-$2.59M-$8.62M$217.68M$128.37M$507.13M$314.94M$273.17M$284.29M
Income tax$4.47M-$1.33M-$4.40M-$5.48M-$9.42M-$3.26M-$4.42M-$9.62M$4.35M$9.28M
Net income$627.75M$414.17M$1.06B$45.53M$413.56M$505.54M$500.45M$306.01M$243.14M$71.35M
EPS (basic)$1.34$0.88$2.25$0.09$0.77$0.93$0.92$0.56$0.36$0.10
EPS (diluted)$1.34$0.88$2.24$0.09$0.77$0.93$0.92$0.56$0.36$0.10
Diluted shares467.40M468.94M475.39M489.33M531.06M539.24M539.15M547.27M676.23M696.04M
Gross margin65.3%-27.1%-162.6%-180.8%-79.3%-64.1%-74.4%-71.0%-89.1%—
Net margin29.5%79.0%735.8%31.5%94.7%107.3%101.1%58.0%42.8%11.8%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$94.73M$55.31M$53.98M$80.40M$44.23M$158.29M$72.03M$117.64M$119.82M$467.46M
Goodwill$42.00M$47.00M$47.00M$17.00M$18.00M$18.00M$18.00M$18.03M$68.53M$68.53M
Total assets$15.76B$14.09B$12.72B$14.03B$15.92B$15.26B$15.77B$15.70B$19.94B$20.34B
Long-term debt$9.10B$7.79B$5.48B$6.30B$6.62B$6.17B$6.50B$6.88B$8.72B$9.85B
Total debt$9.10B$7.79B$5.48B$6.30B$6.62B$6.17B$6.50B$6.88B$8.72B$9.85B
Total liabilities$9.82B$8.49B$6.21B$7.37B$8.57B$8.11B$8.48B$8.77B$10.88B$12.03B
Shareholders' equity$5.55B$5.30B$5.94B$6.09B$6.73B$6.52B$6.65B$6.35B$8.40B$7.50B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$1.21B$847.04M$848.71M$846.07M$758.43M$795.25M$900.26M$956.24M$1.07B$1.25B
Capital expenditures$458.90M$471.78M$560.88M$677.27M$788.89M$759.72M$961.99M$774.56M$736.76M$894.95M
Free cash flow$755.23M$375.26M$287.83M$168.80M-$30.46M$35.53M-$61.73M$181.68M$333.73M$357.01M
Investing cash flow-$428.97M$1.25B$1.83B-$1.45B-$1.01B$531.03M-$876.34M-$576.75M-$113.80M-$1.03B
Financing cash flow-$1.05B-$2.15B-$2.62B$647.27M$246.45M-$1.29B-$116.53M-$337.30M-$941.42M$136.11M
Dividends paid$979.54M$694.96M$696.91M$720.12M$787.07M$650.08M$648.05M$657.02M$794.78M$849.10M
Share buybacks$8.69M$4.79M$3.43M$5.04M$10.53M$12.84M$67.84M$6.52M$190.69M$97.14M
Stock-based compensation$22.88M$14.26M$16.56M$18.16M$17.37M$18.20M$26.46M$14.48M$15.54M$14.41M
Depreciation & amortization$568.11M$534.73M$404.68M$435.19M$553.95M$684.29M$710.57M$749.90M$1.06B$1.06B

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.